1Pachuk CJ, McCallus DE, Weiner DB, et al. DNA vaccineschallenges in delivery. Curr Opin Mol Ther, 2000;2(2) : 188.
2Abdel-Nabi H, Wright GL, Gulfo JV, et al. Monoclonal antibodies and radioimmunoconjugates in the diagnosis and treatment of prostate cancer. Semin Urol,1992;10(1):45.
3Yang D, Chertov O, Bykovskaia SN, et al. Beta-defensins:linking innate and adaptive immunity through dendritic and T cell CCR6. Science, 1999;286(5439) : 525.
4Bostwick DG, Pacelli A, Blute M, et al. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer,1998;82(11) : 2256.
5Wright GL Jr, Grob BM, Haley C, et al. Upregulation of prostate-specific membrane antigen after androgen-deprivatlon therapy. Urology,1996;48(2) : 326.
6Wolff JA, Ludtke J J, Acsadi G, et al. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle.Hum Mol Genet, 1992;1(6) : 363.
7Davis HL, Mancini M, Michel ML, et al. DNA-medlated immunization to hepatitis B surface antigen:longevity of primary response and effect of boost. Vaccine, 1996; 14(9) : 910.
8Biragyn A, Surenhu M, Yang D, et al. Mediators of innate immunity that target immature, but not mature, Dendritic Cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens. The Journal of Immunology,2001,167:6644.
9Yang D, Biragyn A, Kwak LW, et al. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol,2002,23(6):291.
10Grimm E A,Mazumber A,Zhang H Z,et al.Lymphokine-activated killer cell phenomenon.Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.J Med Exp,1982,155(6):1823-1841.
